Total Payments
$47,210
2024 Payments
$19,007
Companies
6
Transactions
164
Medicare Patients
473
Medicare Billing
$24,888
Payment Breakdown by Category
Other$29,590 (62.7%)
Travel$11,467 (24.3%)
Food & Beverage$5,478 (11.6%)
Consulting$675.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,590 | 33 | 62.7% |
| Travel and Lodging | $11,467 | 27 | 24.3% |
| Food and Beverage | $5,478 | 103 | 11.6% |
| Consulting Fee | $675.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $37,107 | 122 | $0 (2024) |
| ABBVIE INC. | $8,684 | 23 | $0 (2022) |
| INTERCEPT PHARMACEUTICALS, INC. | $976.03 | 13 | $0 (2022) |
| Madrigal Pharmaceuticals | $317.75 | 4 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $103.29 | 1 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $22.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,007 | 60 | Gilead Sciences, Inc. ($18,563) |
| 2023 | $8,832 | 25 | Gilead Sciences, Inc. ($8,832) |
| 2022 | $12,307 | 50 | Gilead Sciences, Inc. ($6,730) |
| 2021 | $7,065 | 29 | AbbVie Inc. ($3,555) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.90 | General |
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.61 | General |
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $132.68 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $115.40 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $85.72 | General |
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $52.14 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: HCV | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.00 | General |
| 10/22/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,710.00 | General |
| Category: HCV | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $707.00 | General |
| Category: HCV | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $707.00 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $1,302.66 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $1,290.73 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $1,290.73 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $127.10 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $127.08 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $127.08 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $63.40 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: HCV | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: HCV | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $119.59 | General |
| Category: INFLAM | ||||||
| 10/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: LIVER DISEASE | ||||||
| 09/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.70 | General |
| 08/08/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $315.00 | General |
| 06/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.47 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 84 | 94 | $21,308 | $5,562 |
| 2022 | 4 | 95 | 111 | $23,323 | $6,152 |
| 2021 | 5 | 142 | 156 | $29,276 | $7,582 |
| 2020 | 4 | 152 | 167 | $28,056 | $5,592 |
Total Patients
473
Total Services
528
Medicare Billing
$24,888
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 24 | $5,640 | $1,555 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 15 | $4,755 | $1,272 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 14 | $4,438 | $1,264 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $2,940 | $627.70 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 16 | $2,560 | $615.30 | 24.0% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Facility | 2023 | 13 | 13 | $975.00 | $228.97 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 20 | 29 | $9,337 | $2,659 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 22 | 25 | $5,875 | $1,594 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 24 | 28 | $4,480 | $1,042 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $3,055 | $762.36 | 25.0% |
| 91200 | Measurement of liver stiffness | Facility | 2022 | 16 | 16 | $576.00 | $93.35 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 36 | $8,460 | $2,444 | 28.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 35 | 41 | $6,752 | $1,672 | 24.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 14 | $4,582 | $1,298 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $3,760 | $989.04 | 26.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 11 | 11 | $2,618 | $636.22 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 14 | $2,240 | $391.32 | 17.5% |
| 91200 | Measuring the stiffness in the liver via elastography | Facility | 2021 | 24 | 24 | $864.00 | $151.00 | 17.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 31 | 36 | $8,580 | $1,767 | 20.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 47 | 53 | $8,672 | $1,720 | 19.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 29 | $4,640 | $1,021 | 22.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 20 | 20 | $5,120 | $889.49 | 17.4% |
| 91200 | Measuring the stiffness in the liver via elastography | Facility | 2020 | 29 | 29 | $1,044 | $194.20 | 18.6% |
About Jennifer Scheuermann, PA-C
Jennifer Scheuermann, PA-C is a Physician Assistant healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922016757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Scheuermann, PA-C has received a total of $47,210 in payments from pharmaceutical and medical device companies, with $19,007 received in 2024. These payments were reported across 164 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,590).
As a Medicare-enrolled provider, Scheuermann has provided services to 473 Medicare beneficiaries, totaling 528 services with total Medicare billing of $24,888. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location New Orleans, LA
- Active Since 08/04/2006
- Last Updated 11/19/2008
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1922016757
Products in Payments
- Epclusa (Drug) $32,152
- MAVYRET (Drug) $7,334
- OCALIVA (Drug) $976.03
- CREON (Drug) $675.00
- RESMETIROM (Drug) $317.75
- Vemlidy (Drug) $123.89
- Livdelzi (Drug) $119.59
- GIVLAARI (Drug) $103.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in New Orleans
Claire Darre, Pa-C, PA-C
Physician Assistant — Payments: $49,989
Physician Assistant $49,989
David G'sell, Pa, PA
Physician Assistant — Payments: $25,618
Physician Assistant $25,618
Elizabeth Clement
Physician Assistant — Payments: $17,319
Physician Assistant $17,319
Sydney Tsen, Pa-C, PA-C
Physician Assistant — Payments: $12,526
Physician Assistant $12,526
Nakia Brooks, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $11,265
Physician Assistant $11,265
Richard Tubbs, Phd,Pa-C, PHD,PA-C
Physician Assistant — Payments: $9,466
Physician Assistant $9,466